Shopping Cart
- Remove All
- Your shopping cart is currently empty
BMT-124110 is a selective AAK1 inhibitor (IC50: 0.9 nM) with antinociceptive activity. BMT-090605 inhibited BMP-2 induced protein kinase BIKE with IC50 of 17 nM. BMT-090605 inhibits cyclin G-associated kinase GAK with an IC50 of 99 nM.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $329 | In Stock | |
5 mg | $798 | In Stock | |
10 mg | $1,090 | In Stock | |
25 mg | $1,650 | 8-10weeks | |
50 mg | $2,230 | 8-10weeks | |
1 mL x 10 mM (in DMSO) | $953 | In Stock |
Description | BMT-124110 is a selective AAK1 inhibitor (IC50: 0.9 nM) with antinociceptive activity. BMT-090605 inhibited BMP-2 induced protein kinase BIKE with IC50 of 17 nM. BMT-090605 inhibits cyclin G-associated kinase GAK with an IC50 of 99 nM. |
Targets&IC50 | GAK:99 nM, AAK1:0.9 nM |
In vitro | BMT-124110 presents a cellular IC50 of 3.2 nM for AAK1[1]. |
In vivo | BMT-124110 is added directly to the spine by microion electrophoresis. Wind-induced activity decreased in 10 of the 14 animals.[1] |
Molecular Weight | 369.46 |
Formula | C21H27N3O3 |
Cas No. | 1679371-59-5 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 27.5 mg/mL (74.43 mM) | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.